Bufexamac

Bufexamac Struktur
2438-72-4
CAS-Nr.
2438-72-4
Bezeichnung:
Bufexamac
Englisch Name:
Bufexamac
Synonyma:
j3;cp1044;feximac;mofenar;parfenac;droxaryl;droxarol;cp1044j3;flogicid;norfemac
CBNumber:
CB7768637
Summenformel:
C12H17NO3
Molgewicht:
223.27
MOL-Datei:
2438-72-4.mol

Bufexamac Eigenschaften

Schmelzpunkt:
153-155°
Siedepunkt:
364.56°C (rough estimate)
Dichte
1.1223 (rough estimate)
Brechungsindex
1.5300 (estimate)
storage temp. 
Inert atmosphere,Store in freezer, under -20°C
Löslichkeit
Practically insoluble in water, soluble in dimethylformamide, slightly soluble in ethyl acetate and in methanol.
pka
9.24±0.20(Predicted)
Farbe
White to Off-White
Merck 
14,1474
CAS Datenbank
2438-72-4(CAS DataBase Reference)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
WGK Germany  2
RTECS-Nr. AK8280000
HS Code  2928.00.2500
Toxizität LD50 orally in mice, rats: >8, >4 g/kg (Lambelin)
Bildanzeige (GHS) GHS hazard pictograms
Alarmwort Warnung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H317 Kann allergische Hautreaktionen verursachen. Sensibilisierung der Haut Kategorie 1A Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P261, P272, P280, P302+P352,P333+P313, P321, P363, P501
Sicherheit
P261 Einatmen von Staub vermeiden.
P272 Kontaminierte Arbeitskleidung nicht außerhalb des Arbeitsplatzes tragen.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P501 Inhalt/Behälter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen.

Bufexamac Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

White Solid

Verwenden

Bufexamac is a specific inhibitor of class IIB histone deacetylases (HDAC6 and HDAC10). Bufexamac is a non-steroidal anti-inflammatory drug used topically as well as rectally. Formulations containing Bufexamac is used by many patients with eczematous disorders as an alternative to topical corticosteroids.

Definition

ChEBI: A hydroxamic acid derived from phenylacetamide in which the benzene moiety is substituted at C-4 by a butoxy group. It has anti-inflammatory, analgesic, and antipyretic properties.

Weltgesundheitsorganisation (WHO)

Bufexamac, an analgesic and anti-inflammatory agent, was introduced in 1974 for the topical treatment of a wide range of dermatoses. The drug is widely marketed and the World Health Organization is not aware of restrictive action having been taken elsewhere.

Kontakt-Allergie

Bufexamac is an arylacetic nonsteroidal anti-inflammatory drug. It induces allergic contact dermatitis, eczematous or erythema multiforme like type, and even generalized eruptions like acute generalized exanthematous pustulosis.

Bufexamac Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Bufexamac Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 251)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21688 55
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
Nanjing Dolon Biotechnology Co.,Ltd.
18905173768
sales@dolonchem.com CHINA 2972 58
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28180 58
Xiamen Shindano Biotechnology Co.,ltd
0592-6266840 15750707980
sales@chemsdano.com CHINA 93 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58
SIMAGCHEM CORP
+86-13806087780
sale@simagchem.com China 17367 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Hefei TNJ Chemical Industry Co.,Ltd.
0551-65418671
sales@tnjchem.com China 34572 58
ANHUI WITOP BIOTECH CO., LTD
+8615255079626
eric@witopchemical.com China 23556 58

2438-72-4(Bufexamac)Verwandte Suche:


  • 2-(p-butoxyphenyl)-acetohydroxamicaci
  • 4-butoxy-n-hydroxy-benzeneacetamid
  • 4-butoxy-n-hydroxybenzeneacetamide
  • 4-butoxyphenylacetohydroxamicacid
  • acidep-butoxyphenylacethydroxamique
  • bufexamicacid
  • cp1044
  • cp1044j3
  • droxarol
  • droxaryl
  • parfenac
  • p-butoxyphenylacetohydroxamicacid
  • AURORA KA-853
  • BUFEXAMAC
  • 2-(4-BUTOXYPHENYL)-N-HYDROXYACETAMIDE
  • LABOTEST-BB LT00134645
  • 2-(p-butoxyphenyl)acetohydroxamic acid
  • 2-(4-butoxyphenyl)acetohydroxamic acid
  • 4-Butoxyphenylacethydroxamic acid
  • p-Butoxyphenylacethydroxamic acid
  • 2-(p-Butoxyphenyl)acetohydoroximic acid
  • 2-(4-butoxyphenyl)ethanehydroxamic acid
  • 2-(4-butoxyphenyl)-N-hydroxy-ethanamide
  • Bufexamac, >=98%
  • feximac
  • flogicid
  • flogocidnplastigel
  • j3
  • malipuran
  • mofenar
  • norfemac
  • Bufexamac, 98%, a COX inhibitor
  • tantalum(2+)
  • Bufexamac CRS
  • Bufexamac >
  • Benzeneacetamide, 4-butoxy-N-hydroxy-
  • Bufexamac USP/EP/BP
  • Bufexamac (Bufexamic acid)
  • Bufexamac, ≥ 98.0%
  • 2438-72-4
  • C12H17NO3
  • Analytical Standards
  • Alphabetic
  • Analytical Chromatography Product Catalog
  • BI - BZ
  • API
  • NORFEMAC
  • Chemistry
  • Miscellaneous
  • Lipid signaling
Copyright 2019 © ChemicalBook. All rights reserved